Genetics of polycystic ovary syndrome

Seminars in Reproductive Medicine

Volumn 32, Issue 3, 2014, Pages 177-182

  Welt, Corrine K ^a   Duran, Jessica M ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

genome wide association; gonadotropins; hyperandrogenism

Indexed keywords

ANDROSTENEDIONE; FOLLITROPIN; GONADOTROPIN; INSULIN; LUTEINIZING HORMONE; TESTOSTERONE;

ARTICLE; ETHNICITY; EXOCYTOSIS; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENETICS; GENOTYPE; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; PHENOTYPE; QUANTITATIVE TRAIT; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION;

FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84898471256     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0034-1371089     Document Type: Article

References (52)

1. Knochenhauer E. S., Key T. J., Kahsar-Miller M., Waggoner W., Boots L. R., Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab: 1998; 83 9 3078 3082 (Pubitemid 28500937)
2. Diamanti-Kandarakis E., Kouli C. R., Bergiele A. T., et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab: 1999; 84 11 4006 4011 (Pubitemid 30644187)
3. Asunción M., Calvo R. M., San Millán J. L., Sancho J., Avila S., Escobar-Morreale H. F. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab: 2000; 85 7 2434 2438 (Pubitemid 32269197)
4. Taylor A. E., McCourt B., Martin K. A., et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab: 1997; 82 7 2248 2256 (Pubitemid 27287593)
5. Rebar R., Judd H. L., Yen S. SC, Rakoff J., Vandenberg G., Naftolin F. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest: 1976; 57 5 1320 1329
6. Waldstreicher J., Santoro N. F., Hall J. E., Filicori M., Crowley W. F. Jr. Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. J Clin Endocrinol Metab: 1988; 66 1 165 172 (Pubitemid 18027747)
7. Chang R. J., Nakamura R. M., Judd H. L., Kaplan S. A. Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab: 1983; 57 2 356 359 (Pubitemid 13032489)
8. Dunaif A., Segal K. R., Futterweit W., Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes: 1989; 38 9 1165 1174 (Pubitemid 19250404)
9. Stein I. F., Leventhal M. L. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol: 1935; 29 181 191
10. Adams J., Polson D. W., Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed): 1986; 293 6543 355 359 (Pubitemid 16034121)
11. Pigny P., Merlen E., Robert Y., et al. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab: 2003; 88 12 5957 5962 (Pubitemid 38033078)
12. Adams J. M., Taylor A. E., Crowley W. F. Jr, Hall J. E. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. J Clin Endocrinol Metab: 2004; 89 9 4343 4350 (Pubitemid 39244436)
13. Legro R. S., Chiu P., Kunselman A. R., Bentley C. M., Dodson W. C., Dunaif A. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype. J Clin Endocrinol Metab: 2005; 90 5 2571 2579 (Pubitemid 40686293)
14. Welt C. K., Arason G., Gudmundsson J. A., et al. Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations. J Clin Endocrinol Metab: 2006; 91 11 4361 4368 (Pubitemid 44833410)
15. National Institutes of Health Evidence-Based Methodology Workshop on Polycystic Ovary Syndrome: Executive Summary. Washington: National Institutes of Health: 2013. Available at: prevention nih gov/workshops/2012/pcos/docs/PCOS- Final-Statement pdf. Accessed on October 1, 2013
16. Cussons A. J., Stuckey B. G., Walsh J. P., Burke V., Norman R. J. Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management. Clin Endocrinol (Oxf): 2005; 62 3 289 295 (Pubitemid 40380408)
17. Vink J. M., Sadrzadeh S., Lambalk C. B., Boomsma D. I. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab: 2006; 91 6 2100 2104 (Pubitemid 43854989)
18. Spielman R. S., Ewens W. J. The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet: 1996; 59 5 983 989 (Pubitemid 26346336)
19. Altshuler D., Hirschhorn J. N., Klannemark M., et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet: 2000; 26 1 76 80
20. Pau C., Saxena R., Welt C. K. Evaluating reported candidate gene associations with polycystic ovary syndrome. Fertil Steril: 2013; 99 6 1774 1778
21. Ewens K. G., Stewart D. R., Ankener W., et al. Family-based analysis of candidate genes for polycystic ovary syndrome. J Clin Endocrinol Metab: 2010; 95 5 2306 2315
22. Urbanek M. The genetics of the polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab: 2007; 3 2 103 111 (Pubitemid 46146963)
23. Lander E. S., Linton L. M., Birren B., et al. International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature: 2001; 409 6822 860 921 (Pubitemid 32165345)
24. International HapMap Consortium A haplotype map of the human genome. Nature: 2005; 437 7063 1299 1320
25. Hirschhorn J. N., Daly M. J. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet: 2005; 6 2 95 108 (Pubitemid 40179532)
26. Wang W. Y., Barratt B. J., Clayton D. G., Todd J. A. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet: 2005; 6 2 109 118 (Pubitemid 40179533)
27. Chen Z. J., Zhao H., He L., et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet: 2011; 43 1 55 59
28. Shi Y., Zhao H., Shi Y., et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet: 2012; 44 9 1020 1025
29. Goodarzi M. O., Jones M. R., Li X., et al. Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J Med Genet: 2012; 49 2 90 95
30. Lerchbaum E., Trummer O., Giuliani A., Gruber H. J., Pieber T. R., Obermayer-Pietsch B. Susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21, and 9q33.3 in a cohort of Caucasian women. Horm Metab Res: 2011; 43 11 743 747
31. Welt C. K., Styrkarsdottir U., Ehrmann D. A., et al. Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry. J Clin Endocrinol Metab Res: 2012; 97 7 E1342 E1347
32. Louwers Y. V., Stolk L., Uitterlinden A. G. Replication of Chinese PCOS susceptibility loci in patients diagnosed with PCOS from Caucasian descent. Poster presented at: 95th Annual Meeting of the Endocrine Society; June 15-18, 2013; San Francisco, CA. Poster MON-549
33. Marat A. L., Dokainish H., McPherson P. S. DENN domain proteins: regulators of Rab GTPases. J Biol Chem: 2011; 286 16 13791 13800
34. Tasaka K., Masumoto N., Mizuki J., et al. Rab3B is essential for GnRH-induced gonadotrophin release from anterior pituitary cells. J Endocrinol: 1998; 157 2 267 274 (Pubitemid 28238030)
35. Zeggini E., Scott L. J., Saxena R., et al. Wellcome Trust Case Control Consortium. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet: 2008; 40 5 638 645 (Pubitemid 351601209)
36. Mutharasan P., Galdones E., Peñalver Bernabé B., et al. Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry. J Clin Endocrinol Metab: 2013; 98 1 E185 E190
37. Kawamura K., Cheng Y., Suzuki N., et al. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment [published ahead of print September 30, 2013]. PNAS. doi:10.1073/pnas.1312830110
38. Wang H., Jin Y., Reddy M. V., et al. Genetically dependent ERBB3 expression modulates antigen presenting cell function and type 1 diabetes risk. PLoS ONE: 2010; 5 7 e11789
39. McCarthy M. I., Hirschhorn J. N. Genome-wide association studies: potential next steps on a genetic journey. Hum Mol Genet: 2008; 17 (R2): R156 R165
40. Todd J. A. Statistical false positive or true disease pathway? Nat Genet: 2006; 38 7 731 733 (Pubitemid 43982542)
41. Tsao H., Florez J. C. Introduction to genetic association studies. J Invest Dermatol: 2007; 127 10 2283 2287 (Pubitemid 47619767)
42. Cui L., Zhao H., Zhang B., et al. Genotype-phenotype correlations of PCOS susceptibility SNPs identified by GWAS in a large cohort of Han Chinese women. Hum Reprod: 2013; 28 2 538 544
43. Strauss J. F. III, McAllister J. M., Urbanek M. Persistence pays off for PCOS gene prospectors. J Clin Endocrinol Metab: 2012; 97 7 2286 2288
44. Saxena R., Welt C. K. Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes. Acta Diabetol: 2013; 50 3 451 457
45. Ewens K. G., Jones M. R., Ankener W., et al. Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome. Fertil Steril: 2011; 95 8 2538 2541, e1-e6
46. Biyasheva A., Legro R. S., Dunaif A., Urbanek M. Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2. J Clin Endocrinol Metab: 2009; 94 7 2617 2625
47. Voight B. F., Scott L. J., Steinthorsdottir V., et al. MAGIC investigators; GIANT Consortium. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet: 2010; 42 7 579 589
48. Lyssenko V., Lupi R., Marchetti P., et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest: 2007; 117 8 2155 2163 (Pubitemid 47219560)
49. Frayling T. M., Timpson N. J., Weedon M. N., et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science: 2007; 316 5826 889 894 (Pubitemid 46764279)
50. Ewens K. G., Jones M. R., Ankener W., et al. FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome. PLoS ONE: 2011; 6 1 e16390
51. Barber T. M., Bennett A. J., Groves C. J., et al. Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome. Diabetologia: 2008; 51 7 1153 1158
52. Li T., Wu K., You L., et al. Common variant rs9939609 in gene FTO confers risk to polycystic ovary syndrome. PLoS ONE: 2013; 8 7 e66250